The Impact of the COVID-19 Pandemic on Diagnosing and Treating Attention Deficit Hyperactivity Disorder: New Challenges on Initializing and Optimizing Pharmacological Treatment
IntroductionCOVID-19 has been causing huge disruptions in mental healthcare services worldwide, including those related to ADHD. Some consequences of the pandemic, such as virtual schooling and remote work, as well as increased telemedicine, have posed new challenges for ADHD diagnosis and treatment...
Main Author: | Daniel Segenreich |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-04-01
|
Series: | Frontiers in Psychiatry |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fpsyt.2022.852664/full |
Similar Items
-
Attention deficit hyperactivity disorder - symptoms, diagnosis and therapy among children and adults.
by: Agata Surowiec, et al.
Published: (2023-08-01) -
Use of Non-Pharmacological Supplementations in Children and Adolescents with Attention Deficit/Hyperactivity Disorder: A Critical Review
by: Eleonora Rosi, et al.
Published: (2020-05-01) -
Attention-deficit/hyperactivity disorder
by: A. M.E. du Plessis
Published: (2015-05-01) -
Viloxazine: A New Non-Stimulant Treatment for Attention-Deficit/Hyperactivity Disorder (ADHD)
by: Wiktoria, et al.
Published: (2024-02-01) -
Medical Comorbidities in Attention Deficit Hyperactivity Disorder
by: Irem Yalug, et al.
Published: (2009-09-01)